You can buy or sell ONCE and other stocks, options, ETFs, and crypto commission-free!
Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. Read More The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.
52 Week High
52 Week Low
-$1.21 per share
Expected Sep 23, Pre-Market